Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Comparison of three scoring methods using the FDA-approved 22C3 immunohistochemistry assay to evaluate PD-L1 expression in breast cancer and their association with clinicopathologic factors
PaperCitations, authors & open-access status
Comparison of three scoring methods using the FDA-approved 22C3 immunohistochemistry assay to evaluate PD-L1 expression in breast cancer and their association with clinicopathologic factors is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 71 citations, 2020 year and gold oa status.
71
Citations
2020
Year
gold
OA Status